Contribution of single-pill combinations in the management of hypertension: perspectives from China, Europe and the USA
Author:
Affiliation:
1. Merck Healthcare KGaA, Darmstadt, Germany
2. Department of Hypertension and Heart Center, Peking University People’s Hospital, Beijing, China
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2023.2165812
Reference77 articles.
1. World health Organization. Hypertension. [cited November 2022]. Available from https://www.who.int/health-topics/hypertension.
2. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension
3. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
4. An anchored simulated treatment comparison of uptitration of amlodipine compared with a low-dose combination treatment with amlodipine 5 mg/bisoprolol 5 mg for patients with hypertension suboptimally controlled by amlodipine 5 mg monotherapy
5. Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter Study
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The current position of β-blockers in hypertension: guidelines and clinical practice;Current Medical Research and Opinion;2024-04
2. β-blockers are not all the same: pharmacologic similarities and differences, potential combinations and clinical implications;Current Medical Research and Opinion;2024-04
3. Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial;Frontiers in Cardiovascular Medicine;2023-06-19
4. Polypharmacology: promises and new drugs in 2022;Pharmacological Reports;2023-06-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3